Scholarlink

Background <p>This study aimed to investigate the impact of intestinal obstruction (IO) caused by colorectal cancer (CRC) on the cancer prognosis and recurrence patterns. We analyzed recurrence patterns in patients with stage II–III CRC and employed a murine model to elucidate the effects of IO on hepatic immunity.</p> Methods <p>We examined the clinical outcomes of CRC patients with IO and utilized a murine IO model to assess alterations in hepatic immunity, focusing on natural killer (NK) cell function.</p> Results <p>IO was significantly associated with poor prognosis and an increased incidence of liver metastases. In the murine model, IO induced hepatic inflammation and impaired the antitumor activity of liver-resident NK cells, whereas its effects on conventional splenic and pulmonary NK cells were minimal. These findings, consistent between human clinical data and murine experiments, suggest that IO promotes a microenvironment conducive to liver metastasis by compromising hepatic immunity.</p> Conclusions <p>IO exerts a detrimental effect on hepatic immunity by impairing NK cell-mediated antitumor responses, thereby facilitating liver metastasis in CRC.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Intestinal obstruction impairs the antitumor function of hepatic natural killer cells against colorectal cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月6日

查看全文
  • Kouki Imaoka,
  • Masahiro Ohira,
  • Takuya Yano,
  • Tomoaki Bekki,
  • Yuki Imaoka,
  • Ryosuke Nakano,
  • Seiichi Shimizu,
  • Manabu Shimomura,
  • Yuka Tanaka,
  • Tsuyoshi Kobayashi,
  • Hideki Ohdan

摘要

Background

This study aimed to investigate the impact of intestinal obstruction (IO) caused by colorectal cancer (CRC) on the cancer prognosis and recurrence patterns. We analyzed recurrence patterns in patients with stage II–III CRC and employed a murine model to elucidate the effects of IO on hepatic immunity.

Methods

We examined the clinical outcomes of CRC patients with IO and utilized a murine IO model to assess alterations in hepatic immunity, focusing on natural killer (NK) cell function.

Results

IO was significantly associated with poor prognosis and an increased incidence of liver metastases. In the murine model, IO induced hepatic inflammation and impaired the antitumor activity of liver-resident NK cells, whereas its effects on conventional splenic and pulmonary NK cells were minimal. These findings, consistent between human clinical data and murine experiments, suggest that IO promotes a microenvironment conducive to liver metastasis by compromising hepatic immunity.

Conclusions

IO exerts a detrimental effect on hepatic immunity by impairing NK cell-mediated antitumor responses, thereby facilitating liver metastasis in CRC.